LLY - ELI LILLY & Co
869.58
-43.180 -4.966%
Share volume: 4,818,093
Last Updated: 03-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$912.76
-43.18
-0.05%
View ratios
| Fiscal Date | 09-30-2023 | 12-31-2023 | 12-31-2023 | 03-31-2024 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2023 | Q4 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 11-02-2023 | 02-19-2025 | 02-21-2024 | 04-30-2024 | 04-30-2024 | 08-08-2024 | 10-30-2024 | 02-19-2025 | |
| Total revenue | 9.499 B | 9.353 B | 9.353 B | 8.768 B | 8.768 B | 11.303 B | 11.439 B | 13.533 B | |
| Cost of revenue | 1.860 B | 1.788 B | 1.788 B | 1.674 B | 1.674 B | 2.170 B | 2.171 B | 2.404 B | |
| Gross profit | 7.639 B | 7.565 B | 7.565 B | 7.095 B | 7.095 B | 9.133 B | 9.268 B | 11.129 B | |
| -0.96% | 0.00% | -6.22% | 0.00% | 28.73% | 1.49% | 20.08% | |||
| Operating expenses | 4.213 B | 5.110 B | 4.487 B | 4.586 B | 4.475 B | 4.983 B | 7.660 B | 5.636 B | |
| Selling general and admin | 1.804 B | 1.925 B | 1.925 B | 1.952 B | 1.952 B | 2.117 B | 2.100 B | 2.425 B | |
| Research and development | 2.409 B | 3.185 B | 2.563 B | 2.633 B | 2.523 B | 2.866 B | 5.561 B | 3.212 B | |
| Total expenses | 6.073 B | 5.178 B | 6.275 B | 4.586 B | 6.149 B | 5.418 B | 7.742 B | 5.980 B | |
| -14.75% | 21.20% | -26.93% | 34.09% | -11.88% | 42.90% | -22.76% | |||
| Operating income | 3.426 B | 2.388 B | 3.078 B | 2.509 B | 2.620 B | 3.715 B | 1.526 B | 5.149 B | |
| Ebit | 3.426 B | 2.509 B | 3.078 B | 2.536 B | 2.620 B | 3.517 B | 1.588 B | 5.039 B | |
| Pretax income | 427.200 M | 2.509 B | 2.509 B | 2.536 B | 2.536 B | 3.517 B | 1.588 B | 5.039 B | |
| 487.27% | 0.00% | 1.09% | 0.00% | 38.69% | -54.84% | 217.22% | |||
| Income tax | 484.600 M | 319.100 M | 319.100 M | 293.200 M | 293.200 M | 550.200 M | 618.100 M | 628.900 M | |
| Net income basic | -57.400 M | 0.000 | 2.190 B | 0.000 | 2.243 B | 0.000 | 0.000 | 0.000 | |
| 100.00% | -100.00% | -100.00% | |||||||
| Net income | -57.400 M | 2.190 B | 2.190 B | 2.243 B | 2.243 B | 2.967 B | 970.300 M | 4.410 B | |
| 3,914.81% | 0.00% | 2.43% | 0.00% | 32.28% | -67.30% | 354.48% |